Posted on 2/4/21
TK60 Eradicates COVID-19 In 20 Seconds, Independent Laboratory Confirms
Third-party testing conducted by Environmental Protection Agency (EPA) audited Microchem Laboratory confirms that TK60, eliminates 99.99% of COVID-19 in just 20 seconds. This far surpasses the . . .
Posted on 2/4/21
Northern Westchester Hospital Opens State-of-the-art Electrophysiology Lab
Dr. Subbarao Choudry leads program Northern Westchester Hospital’s (NWH) has opened a state-of-the-art Electrophysiology Lab, offering specialized testing, expert diagnosis and advanced treatment for all types . . .
Posted on 2/4/21
Vigene Biosciences Plans Major Expansion in Montgomery County, Adding up to 245 New Jobs
Vigene Biosciences, a global leader in gene therapy development, has announced plans to expand into a new facility in Montgomery County to accommodate industry demand for . . .
Posted on 2/4/21
Quest Diagnostics Reports Fourth Quarter And Full Year 2020 Financial Results
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced today financial results for the fourth quarter and full year ended December 31, . . .
Posted on 2/4/21
BrainStorm Announces Full Year 2020 Financial Results and Provides a Corporate Update
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today financial results for the fiscal year ended December 31, . . .
Posted on 2/4/21
AmerisourceBergen Reports Fiscal 2021 First Quarter Results
VALLEY FORGE, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today reported that in its fiscal year 2021 first quarter ended December 31, 2020, revenue increased 9.7 percent year-over-year . . .
Posted on 2/4/21
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and operating results for its third quarter ended . . .
Posted on 2/4/21
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2020
NEW YORK--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today reports results for the fourth quarter and full year of 2020, which reflect robust sales, strong operating performance and advancement . . .
Posted on 2/4/21
Merck Announces Fourth-Quarter and Full-Year 2020 Financial Results
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced financial results for the fourth quarter and full year of . . .
Posted on 2/4/21
Bristol Myers Squibb Tender Offers for Price of Up to $4.0 Billion
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY), with its wholly-owned subsidiary Celgene Corporation, announced the commencement of 20 separate offers to purchase for cash notes issued by . . .
Posted on 2/4/21
TYME Announces $100 Million Registered Direct Offering of Common Stock
BEDMINSTER, N.J.--(BUSINESS WIRE)--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), today announced that it has entered into definitive agreements with . . .
Posted on 2/4/21
EyePoint Pharmaceuticals Closes of $115 Million Public Offering of Common Stock
WATERTOWN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a pharmaceutical company committed to developing and commercializing therapeutics to help improve the . . .
Posted on 2/4/21
Alexion Reports Fourth Quarter and Full Year 2020 Results
BOSTON--(BUSINESS WIRE)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the fourth quarter and full year of 2020. Total revenues for the full year of 2020 . . .
Posted on 2/4/21
Aspira Women’s Health Prices of $45 Million Public Offering of Common Stock
AUSTIN, Texas, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today announced . . .
Posted on 2/4/21
Biogen Cash Tender Offer for 5.200% Senior Notes
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the commencement of an offer to purchase for cash any and all . . .
Posted on 2/4/21
Biogen Announces Private Exchange Offer for 5.200% Senior Notes
CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced the commencement of a private offer to exchange any and all of . . .
Posted on 2/4/21
Replimune Reports Third Fiscal Quarter Financial Results and Provides Corporate Update
WOBURN, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Replimune Group Inc. (NASDAQ: REPL), a biotechnology company developing oncolytic immuno-gene therapies derived from its Immulytic platform, today . . .
Posted on 2/4/21
Prestige Consumer Healthcare Reports Fiscal 2021 Third Quarter Results
TARRYTOWN, N.Y., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its third quarter and first nine months ended . . .
Posted on 2/4/21
Is It Too Late to Buy Pfizer Stock?
Anyone not following the market would probably think that Pfizer (NYSE:PFE) did well last year. With the publicity from a potentially pandemic-ending vaccine and agreements for . . .
Posted on 2/4/21
Why Novavax Stock Should Soar Even Higher
Which stock was the biggest winner among COVID-19 vaccine makers in 2020? Pat yourself on the back if your answer was Novavax (NASDAQ:NVAX). Its shares skyrocketed . . .
Posted on 2/4/21
Why Biogen's Q4 Results Were a Bust
You can almost always know how strong a company's near-term prospects are by looking at its stock price. Biogen's (NASDAQ:BIIB) shares sank more than 17% last . . .
Posted on 2/4/21
State Roundup: Health Dept. Urges Providers To Reserve 2nd COVID VAXX Doses
STATE URGES RESERVE FOR 2nd VACCINE DOSES: Maryland’s acting health secretary, Dennis Schrader, on Tuesday said health care providers should hold in reserve enough COVID-19 vaccine . . .
Posted on 2/4/21
Rhythm Pharmaceuticals Proposed Public Offering
BOSTON, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a biopharmaceutical company aimed at developing and commercializing therapies for the treatment of rare . . .
Posted on 2/4/21
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative . . .
Posted on 2/4/21
Kaleido Biosciences Proposes Public Offering of Common Stock
LEXINGTON, Mass., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome . . .
